Why Are Dysplastic Naevi Classified As An Absolute Contraindication For Aesthetic Laser And Ipl Treatments? Protect Diagnostic Safety

Dysplastic naevi are classified as an absolute contraindication because cosmetic laser or IPL treatment can destroy, alter, or obscure tissue that may need microscopic examination. Once a pigmented lesion has been irradiated, ablated, or significantly modified, a later biopsy may no longer provide a reliable picture of its original architecture. Treatment can therefore delay melanoma diagnosis, leave malignant cells behind, or produce healing changes that resemble melanoma.

The central issue is diagnostic safety, not simply laser sensitivity. A dysplastic or otherwise uncertain naevus must be assessed and, when indicated, biopsied before any cosmetic energy-based treatment because laser or IPL can compromise both diagnosis and follow-up.

Why Diagnosis Must Come First

Dysplastic naevi can resemble melanoma

Dysplastic naevi are atypical melanocytic lesions with clinical or microscopic features that may overlap with melanoma. Their appearance can make it difficult to determine whether a lesion is benign, changing, or already malignant without appropriate dermatological assessment.

A cosmetic practitioner should not assume that an unusual pigmented lesion is harmless merely because it appears stable or resembles other naevi.

Histology requires representative tissue

Histological examination evaluates the lesion’s cellular features and architecture under a microscope. This assessment depends on obtaining tissue that still represents the lesion accurately.

Laser and IPL may thermally damage, vaporise, fragment, or selectively alter pigmented tissue. That can make later histological interpretation incomplete or unreliable, particularly if only residual or treated tissue remains.

Cosmetic treatment can remove evidence of malignancy

A suspicious naevus may contain the most diagnostically important features within specific areas of the lesion. Partial destruction may remove those areas while leaving atypical or malignant cells in deeper or untreated tissue.

This creates a serious risk of incomplete treatment of an undiagnosed melanoma while giving the appearance that the lesion has been addressed.

How Laser and IPL Can Complicate Follow-Up

Treatment can mask future changes

After laser or IPL exposure, inflammation, pigment alteration, scarring, and post-inflammatory hyperpigmentation or hypopigmentation may develop. These changes can obscure the lesion’s subsequent clinical evolution.

A clinician may then have difficulty distinguishing treatment-related change from genuine melanoma progression.

Healing can resemble recurrent melanoma

Altered pigmentation and atypical regrowth after destruction can produce a lesion that resembles melanoma clinically or microscopically. This phenomenon is often described as pseudomelanoma or a recurrent-naevus-like change.

Even when the lesion is ultimately benign, the altered appearance can lead to diagnostic uncertainty, additional procedures, and delayed confidence in the diagnosis.

Long-term biological effects are uncertain

The long-term effects of applying cosmetic laser or IPL energy to dysplastic melanocytic cells are not sufficiently predictable to justify elective treatment. The concern is not limited to immediate burns or pigment changes; it also includes the possibility of altering lesion behaviour or obscuring later malignant transformation.

Because the procedure is cosmetic rather than medically necessary, exposing an uncertain lesion to that risk is unjustified.

Why This Applies to Both Laser and IPL

Different devices create the same safety problem

Laser and IPL devices differ in wavelength, pulse structure, and tissue interaction. Some target melanin selectively, while others produce broader thermal or ablative effects.

Despite these differences, both can alter or destroy pigmented tissue and therefore compromise later assessment. The contraindication is based on the lesion’s diagnostic uncertainty, not on one particular device type.

Pigment-selective treatment is especially concerning

Pigment-targeting systems may preferentially affect melanin-containing cells. That does not guarantee complete removal of the lesion, especially when atypical melanocytes extend beyond the visibly pigmented surface or deeper into the skin.

Residual cells may remain after treatment, while the visible features needed for surveillance have been changed.

The Required Pre-Treatment Decision

Examine every pigmented lesion before treatment

A thorough pre-treatment assessment should identify lesions that are atypical, changing, irregular, symptomatic, or otherwise diagnostically uncertain. These lesions should be documented and excluded from cosmetic treatment until their status is clear.

A practitioner should also avoid treating around a lesion in a way that makes its borders or future changes more difficult to monitor.

Refer when malignancy cannot be excluded

If a lesion cannot confidently be classified as benign, it requires evaluation by an appropriately qualified dermatologist or other clinician. Dermoscopy, serial monitoring, or biopsy may be appropriate depending on the clinical findings.

A cosmetic laser or IPL procedure should never substitute for that diagnostic process.

Biopsy precedes elective destruction

When histological examination is indicated, it should occur before any procedure that could damage the lesion. The treatment decision can be reconsidered only after a clear diagnosis and appropriate clinical advice have been obtained.

Understanding the Trade-Offs

The restriction can prevent a useful cosmetic result

Some benign lesions may be treatable with selected procedures in specialist medical settings. However, that does not make an atypical or pigmented lesion suitable for routine aesthetic laser or IPL treatment.

The priority is preserving diagnostic certainty, even when this means refusing a procedure that might otherwise produce an acceptable cosmetic result.

“Absolute contraindication” does not mean every naevus is untreatable

The term applies to dysplastic, suspicious, or diagnostically uncertain pigmented lesions in the cosmetic-treatment context. It should not be interpreted as a claim that every type of naevus can never be treated under any medical circumstance.

Any exception would require a confirmed diagnosis, appropriate specialist oversight, and a medically justified treatment plan rather than routine aesthetic intervention.

Clinical appearance alone is not always enough

A lesion may look benign but still require assessment because visual inspection cannot reliably exclude melanoma in every case. Treating first and arranging evaluation later reverses the safe order of decisions.

The more uncertain the lesion, the stronger the reason to preserve it for diagnosis.

Making the Right Choice for Your Goal

The practical decision is straightforward: diagnose first, treat cosmetically only when the lesion’s status is established.

If your primary focus is patient safety: Do not irradiate, ablate, or cosmetically remove a dysplastic or suspicious naevus before appropriate dermatological evaluation and histological assessment when indicated.
If your primary focus is diagnostic accuracy: Preserve representative untreated tissue so that a biopsy can assess the lesion’s cellular features and architecture reliably.
If your primary focus is cosmetic improvement: Treat only lesions that have been confidently diagnosed as suitable for the proposed procedure, with specialist input where uncertainty remains.
If your primary focus is practitioner risk management: Document the lesion, decline treatment when its benignity cannot be established, and refer the patient for qualified medical assessment.

Refusing treatment preserves the information needed to detect melanoma early and protects the patient from an avoidable diagnostic delay.

Summary Table:

Reason	Explanation
Diagnostic compromise	Laser/IPL can destroy or alter tissue needed for biopsy, obscuring features of melanoma.
Histological unreliability	Treatment-induced changes hinder accurate microscopic assessment of the lesion.
Risk of incomplete treatment	Partial destruction may leave malignant cells while masking the lesion's appearance.
Pseudomelanoma risk	Healing can resemble melanoma, causing diagnostic confusion.
Long-term uncertainty	Effects on dysplastic cells are unpredictable, delaying diagnosis.

At BELIS, we prioritize patient safety above all. Our state-of-the-art aesthetic equipment is designed for clinics and premium salons that uphold the highest medical standards. By choosing BELIS, you gain access to a comprehensive portfolio—from laser systems to body sculpting—backed by expert training and support. Ensure your practice meets safety protocols while delivering exceptional results. Contact us today to learn more about our solutions and how we can help you grow your business with confidence.